These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33334048)

  • 1. Building Blocks to Design Liposomal Delivery Systems.
    Juszkiewicz K; Sikorski AF; Czogalla A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.
    Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC
    Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain.
    Bayer AM; Alam S; Mattern-Schain SI; Best MD
    Chemistry; 2014 Mar; 20(12):3350-7. PubMed ID: 24615893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
    Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
    Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of thermosensitive liposomal formulations on loading and release of high molecular weight biomolecules.
    Huang X; Li M; Bruni R; Messa P; Cellesi F
    Int J Pharm; 2017 May; 524(1-2):279-289. PubMed ID: 28377318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic liposomes as in vivo delivery vehicles.
    Smyth Templeton N
    Curr Med Chem; 2003 Jul; 10(14):1279-87. PubMed ID: 12678799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated liposomal doxorubicin in ovarian cancer.
    Green AE; Rose PG
    Int J Nanomedicine; 2006; 1(3):229-39. PubMed ID: 17717964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating.
    Oumzil K; Khiati S; Grinstaff MW; Barthélémy P
    J Control Release; 2011 Apr; 151(2):123-30. PubMed ID: 21354443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective-Loading of Platinum-Chloroquine into PEGylated Neutral and Cationic Liposomes as a Drug Delivery System for Resistant Malaria Parasites.
    Ibrahim S; Tagami T; Ozeki T
    Biol Pharm Bull; 2017; 40(6):815-823. PubMed ID: 28566625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
    Erdoğ A; Putra Limasale YD; Keskin D; Tezcaner A; Banerjee S
    J Pharm Sci; 2013 Oct; 102(10):3666-77. PubMed ID: 23897281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of drug-to-lipid ratio to the development of optimized liposomal formulation.
    Chountoulesi M; Naziris N; Pippa N; Demetzos C
    J Liposome Res; 2018 Sep; 28(3):249-258. PubMed ID: 28627268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
    Awad NS; Paul V; Al-Sayah MH; Husseini GA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):705-714. PubMed ID: 30873869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.
    Hu Y; Rip J; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
    J Pharm Sci; 2017 Sep; 106(9):2606-2613. PubMed ID: 28322936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
    Soni PK; Saini TR
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alginate nanogel-embedded liposomal drug carriers facilitate drug delivery efficiency in arthritis treatment.
    Lin X; Li Y; Zhang B; Li J; Ren J; Tang Y; Wu S; Yang J; Wang Q
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):133065. PubMed ID: 38866273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted liposomal drug delivery: a nanoscience and biophysical perspective.
    Liu Y; Castro Bravo KM; Liu J
    Nanoscale Horiz; 2021 Feb; 6(2):78-94. PubMed ID: 33400747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes.
    He Y; Zhang L; Song C
    Int J Nanomedicine; 2010 Sep; 5():697-705. PubMed ID: 20957221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.